Bausch + Lomb (BLCO) vs RxSight (RXST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Bausch + Lomb (BLCO) has outperformed RxSight (RXST) over the past year, gaining 18.3% versus a loss of 42.0%. Bausch + Lomb is the larger company by market cap ($6.19 billion vs $199.6 million), about 31.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BLCO | RXST |
|---|---|---|
| Share price | $17.34 | $4.80 |
| Market cap | $6.19B | $199.65M |
| 1-day change | +0.93% | +3.23% |
| YTD return | +1.52% | -53.93% |
| 1-year return | +18.28% | -42.03% |
| 5-year return | — | -64.60% |
| Forward P/E | 15.58 | — |
| EPS (TTM) | $-0.49 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $5.10B | — |
| Revenue growth (YoY) | +6.47% | — |
| Net income (latest FY) | $-360.00M | — |
| Operating margin | 2.22% | — |
| Net margin | -7.06% | — |
| 52-week high | $18.92 | $13.22 |
| 52-week low | $13.77 | $4.48 |
| Distance from 52-week high | -8.33% | -63.69% |
| Analyst consensus | buy | — |
| Avg. price target upside | +11.82% | — |
| Average volume | 392.81K | 861.88K |
| Shares outstanding | 357.17M | 41.59M |
| Employees | 13,000 | — |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bausch + Lomb is about 31.0 times larger than RxSight by market value ($6.19B vs $199.65M).
- BLCO has outperformed RXST by 60.3 percentage points over the past year.
About Bausch + Lomb
BLCO stock →Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical.
Health Care · Ophthalmic Goods · 13,000 employees
BLCO vs RXST FAQ
Which is bigger, Bausch + Lomb or RxSight?
Bausch + Lomb (BLCO) is larger, with a market capitalization of $6.19B compared with $199.65M for RxSight (RXST).
Which stock has performed better over the past year, BLCO or RXST?
BLCO returned +18.28% over the past 12 months, compared with -42.03% for RXST (price return, excluding dividends). Past performance does not predict future results.
Are Bausch + Lomb and RxSight in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.